Treatment of Bladder Pain Syndrome with Onabotulinum toxin A

Trial Profile

Treatment of Bladder Pain Syndrome with Onabotulinum toxin A

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 May 2017

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Bladder disorders; Interstitial cystitis; Pain
  • Focus Therapeutic Use
  • Acronyms ProBaBle
  • Most Recent Events

    • 16 May 2017 Results (n=19) presented at the 112th Annual Meeting of the American Urological Association
    • 16 Sep 2016 Primary endpoint has been met (Absolute variation of pain intensity in pain VAS from visit 1 (screening) to visit 6 (week 12)), according to the interim results.
    • 16 Sep 2016 Interim pre-planned analysis (n=16) presented at the 46th Annual Meeting of the International Continence Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top